RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Tulsa, OK · +175 more sites
Breast Cancer clinical trials in Tulsa, OK
3 recruiting breast cancer studies with a site in Tulsa, OK.
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Oklahoma City, OK · Tulsa, OK · +825 more sites
RecruitingEarly Phase 1NCT05921253
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Sponsor: University of Oklahoma
Oklahoma City, OK · Tulsa, OK
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.